255 related articles for article (PubMed ID: 18382996)
1. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre.
Clur SA; Mathijssen IB; Pajkrt E; Cook A; Laurini RN; Ottenkamp J; Bilardo CM
Prenat Diagn; 2008 Apr; 28(4):347-54. PubMed ID: 18382996
[TBL] [Abstract][Full Text] [Related]
2. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
Bronshtein M; Zimmer EZ; Blazer S
Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
[TBL] [Abstract][Full Text] [Related]
3. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
[TBL] [Abstract][Full Text] [Related]
4. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
[TBL] [Abstract][Full Text] [Related]
5. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
6. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis.
Wald NJ; Morris JK; Walker K; Simpson JM
Prenat Diagn; 2008 Dec; 28(12):1094-104. PubMed ID: 19009556
[TBL] [Abstract][Full Text] [Related]
8. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
[TBL] [Abstract][Full Text] [Related]
9. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
Yang Y; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
[TBL] [Abstract][Full Text] [Related]
10. The association between congenital heart disease and Down syndrome in prenatal life.
Paladini D; Tartaglione A; Agangi A; Teodoro A; Forleo F; Borghese A; Martinelli P
Ultrasound Obstet Gynecol; 2000 Feb; 15(2):104-8. PubMed ID: 10775990
[TBL] [Abstract][Full Text] [Related]
11. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
Sepulveda W; Wong AE; Dezerega V
Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
[TBL] [Abstract][Full Text] [Related]
12. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
[TBL] [Abstract][Full Text] [Related]
13. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
Müller MA; Clur SA; Timmerman E; Bilardo CM
Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
[TBL] [Abstract][Full Text] [Related]
14. Association of fetal choroid plexus cysts with trisomy 18 in a population previously screened by nuchal translucency thickness measurement.
Cheng PJ; Shaw SW; Soong YK
J Soc Gynecol Investig; 2006 May; 13(4):280-4. PubMed ID: 16697944
[TBL] [Abstract][Full Text] [Related]
15. Prenatally detectable congenital heart defects in fetuses with Down syndrome.
Mogra R; Zidere V; Allan LD
Ultrasound Obstet Gynecol; 2011 Sep; 38(3):320-4. PubMed ID: 21360623
[TBL] [Abstract][Full Text] [Related]
16. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
Atzei A; Gajewska K; Huggon IC; Allan L; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Aug; 26(2):154-7. PubMed ID: 15977311
[TBL] [Abstract][Full Text] [Related]
17. De novo monosomy 9p24.3-pter and trisomy 17q24.3-qter characterised by microarray comparative genomic hybridisation in a fetus with an increased nuchal translucency.
Brisset S; Kasakyan S; L'Herminé AC; Mairovitz V; Gautier E; Aubry MC; Benkhalifa M; Tachdjian G
Prenat Diagn; 2006 Mar; 26(3):206-13. PubMed ID: 16450348
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome for children born after a first-trimester measurement of increased nuchal translucency with a normal karyotype: a retrospective analysis.
Axt-Fliedner R; Hartge D; Chiriac A; Krapp M; Berg C; Geipel A; Germer U; Gembruch U
Ultraschall Med; 2009 Dec; 30(6):558-63. PubMed ID: 19137496
[TBL] [Abstract][Full Text] [Related]
19. Partial monosomy 13q (13q21.32--->qter) and partial trisomy 8p (8p1--->pter) presenting with anencephaly and increased nuchal translucency: array comparative genomic hybridization characterization.
Chen CP; Su YN; Tsai FJ; Lin MH; Wu PC; Chern SR; Lee CC; Pan CW; Wang W
Taiwan J Obstet Gynecol; 2011 Jun; 50(2):205-11. PubMed ID: 21791309
[TBL] [Abstract][Full Text] [Related]
20. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
